Wu TT - Search Results

1

p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.

Huang SP, Wu WJ, Chang WS, Wu MT, Chen YY, Chen YJ, Yu CC, Wu TT, Lee YH, Huang JK, Huang CH. Huang SP, et al. Among authors: wu tt, wu wj, wu mt. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2217-24. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598783

2

Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.

Huang SP, Huang CY, Wu WJ, Pu YS, Chen J, Chen YY, Yu CC, Wu TT, Wang JS, Lee YH, Huang JK, Huang CH, Wu MT. Huang SP, et al. Among authors: wu tt, wu wj, wu mt. Int J Cancer. 2006 Oct 15;119(8):1902-7. doi: 10.1002/ijc.22053. Int J Cancer. 2006. PMID: 16708371 Free article.

3

Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.

Huang SP, Huang CY, Wang JS, Liu CC, Pu YS, Yu HJ, Yu CC, Wu TT, Huang CH, Wu WJ, Chou YH, Wu MT. Huang SP, et al. Among authors: wu tt, wu wj, wu mt. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6632-8. doi: 10.1158/1078-0432.CCR-07-1437. Clin Cancer Res. 2007. PMID: 18006764

4

CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.

Huang SP, Yu CC, Liu CC, Wu TT, Huang CH, Wu MT. Huang SP, et al. Among authors: wu tt, wu mt. Urol Int. 2008;81(1):36-40. doi: 10.1159/000137638. Epub 2008 Jul 16. Urol Int. 2008. PMID: 18645269

5

Influence of cytokine gene polymorphisms on prostate-specific antigen recurrence in prostate cancer after radical prostatectomy.

Lin HC, Liu CC, Kang WY, Yu CC, Wu TT, Wang JS, Wu WJ, Huang CH, Wu MT, Huang SP. Lin HC, et al. Among authors: wu tt, wu wj, wu mt. Urol Int. 2009;83(4):463-70. doi: 10.1159/000251189. Epub 2009 Dec 8. Urol Int. 2009. PMID: 19996656

6

Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population.

Huang SP, Chou YH, Wayne Chang WS, Wu MT, Chen YY, Yu CC, Wu TT, Lee YH, Huang JK, Wu WJ, Huang CH. Huang SP, et al. Among authors: wu tt, wu wj, wu mt. Cancer Lett. 2004 Apr 15;207(1):69-77. doi: 10.1016/j.canlet.2003.12.006. Cancer Lett. 2004. PMID: 15050735

7

Expression of vascular endothelial growth factor in Taiwanese benign and malignant prostate tissues.

Wu TT, Wang JS, Jiann BP, Yu CC, Tsai JY, Lin JT, Huang JK. Wu TT, et al. J Chin Med Assoc. 2007 Sep;70(9):380-4. doi: 10.1016/S1726-4901(08)70024-8. J Chin Med Assoc. 2007. PMID: 17908652 Free article.

8

Correlation of p53 protein accumulation and Bcl-2 overexpression with histopathological features in prostatic cancer.

Lin JT, Wang JS, Jiann BP, Yu CC, Tsai JY, Huang JK, Wu TT. Lin JT, et al. Among authors: wu tt. J Formos Med Assoc. 2005 Nov;104(11):864-7. J Formos Med Assoc. 2005. PMID: 16496070

9

Clinical outcome of Taiwanese men with clinically localized prostate cancer post-radical prostatectomy: a comparison with other ethnic groups.

Huang SP, Huang CY, Liu CC, Yu CC, Pu YS, Chueh SC, Yu HJ, Wu TT, Li CC, Huang CH, Wu WJ. Huang SP, et al. Among authors: wu tt, wu wj. Aging Male. 2010 Mar;13(1):10-7. doi: 10.3109/13685530903294370. Aging Male. 2010. PMID: 19883296

10

Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy.

Huang SP, Bao BY, Wu MT, Choueiri TK, Goggins WB, Liu CC, Huang CY, Pu YS, Yu CC, Wu TT, Huang CN, Huang CH, Wu WJ. Huang SP, et al. Among authors: wu tt, wu wj, wu mt. Aging Male. 2012 Mar;15(1):34-41. doi: 10.3109/13685538.2011.580398. Epub 2011 May 26. Aging Male. 2012. PMID: 21615239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,053 results

Search Page